These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 27282282)
1. Down-regulation of miR-133a as a poor prognosticator in non-small cell lung cancer. Wang Y; Li J; Chen H; Mo Y; Ye H; Luo Y; Guo K; Mai Z; Zhang Y; Chen B; Zhou Y; Yang Z Gene; 2016 Oct; 591(2):333-7. PubMed ID: 27282282 [TBL] [Abstract][Full Text] [Related]
2. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients. Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406 [TBL] [Abstract][Full Text] [Related]
3. MiR-133a is downregulated in non-small cell lung cancer: a study of clinical significance. Lan D; Zhang X; He R; Tang R; Li P; He Q; Chen G Eur J Med Res; 2015 Apr; 20(1):50. PubMed ID: 25903369 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-153 expression and prognosis in non-small cell lung cancer. Chen WJ; Zhang EN; Zhong ZK; Jiang MZ; Yang XF; Zhou DM; Wang XW Int J Clin Exp Pathol; 2015; 8(7):8671-5. PubMed ID: 26339455 [TBL] [Abstract][Full Text] [Related]
5. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival. Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of microRNA-124 is correlated with tumor metastasis and poor prognosis in patients with lung cancer. Zhang Y; Li H; Han J; Zhang Y Int J Clin Exp Pathol; 2015; 8(2):1967-72. PubMed ID: 25973090 [TBL] [Abstract][Full Text] [Related]
7. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance. Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer. Yang J; Liu H; Wang H; Sun Y Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival. Ge H; Li B; Hu WX; Li RJ; Jin H; Gao MM; Ding CM Int J Clin Exp Pathol; 2015; 8(1):800-5. PubMed ID: 25755777 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC. Liu L; Qu W; Zhong Z Int J Clin Exp Pathol; 2015; 8(5):5609-13. PubMed ID: 26191272 [TBL] [Abstract][Full Text] [Related]
11. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer. Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230 [TBL] [Abstract][Full Text] [Related]
12. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer. Guo W; Zhang Y; Zhang Y; Shi Y; Xi J; Fan H; Xu S Int J Mol Med; 2015 Dec; 36(6):1720-6. PubMed ID: 26497897 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Zhang JG; Wang JJ; Zhao F; Liu Q; Jiang K; Yang GH Clin Chim Acta; 2010 Jun; 411(11-12):846-52. PubMed ID: 20223231 [TBL] [Abstract][Full Text] [Related]
14. Serum level of microRNA-147 as diagnostic biomarker in human non-small cell lung cancer. Chu G; Zhang J; Chen X J Drug Target; 2016 Aug; 24(7):613-7. PubMed ID: 26581116 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer. Tang R; Liang L; Luo D; Feng Z; Huang Q; He R; Gan T; Yang L; Chen G Med Sci Monit; 2015 Aug; 21():2514-20. PubMed ID: 26305739 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of microRNA-133a Expression and Its Clinicopathologic Significance in Non-Small Cell Lung Cancer: A Comprehensive Study Based on Meta-Analysis and the TCGA Database. Yang ZQ; Wu CA; Cheng YX Oncol Res Treat; 2018; 41(12):762-768. PubMed ID: 30458455 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of MicroRNA-221 is associated with poor prognosis in non-small cell lung cancer patients. Zhang Y; Zhao Y; Sun S; Liu Z; Zhang Y; Jiao S Tumour Biol; 2016 Aug; 37(8):10155-60. PubMed ID: 26831656 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer. Yin QW; Sun XF; Yang GT; Li XB; Wu MS; Zhao J Int J Clin Exp Pathol; 2015; 8(1):842-6. PubMed ID: 25755784 [TBL] [Abstract][Full Text] [Related]
19. microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells. Huang J; Sun C; Wang S; He Q; Li D Mol Biosyst; 2015 Jul; 11(7):2051-9. PubMed ID: 25988292 [TBL] [Abstract][Full Text] [Related]
20. Increasing expression of miR-5100 in non-small-cell lung cancer and correlation with prognosis. Wang T; Liu X; Tian Q; Liang T; Chang P Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3592-3597. PubMed ID: 28925485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]